A co-located Phase I unit and bioanalytical lab is a major Celerion asset. This affords tremendous opportunities for FIH/Phase I studies requiring fast processing/analysis of samples. Studies employing time critical Flow and/or EliSpot assays are standout beneficiaries. It can also help reduce dose escalation timelines if PK or other data is needed - no shipping time to consider.
A co-located Clinic and Bioanalytical lab allows for robust PBMC sample integrity, immediate sample analysis & saves on shipping costs. Learn more about what our site in Lincoln, NE has to offer: https://lnkd.in/eQ5f88Jb Learn more about our bioanalytical services: https://lnkd.in/g2B35hU2 #BioanalyticalInnovation #HealthcareEfficiency #LabLife #MedicalResearch